240 related articles for article (PubMed ID: 35077194)
1. Prospective Surveillance for Breast Cancer-Related Arm Lymphedema: A Systematic Review and Meta-Analysis.
Rafn BS; Christensen J; Larsen A; Bloomquist K
J Clin Oncol; 2022 Mar; 40(9):1009-1026. PubMed ID: 35077194
[TBL] [Abstract][Full Text] [Related]
2. Clinical application of axillary reverse mapping in patients with breast cancer: A systematic review and meta-analysis.
Wijaya WA; Peng J; He Y; Chen J; Cen Y
Breast; 2020 Oct; 53():189-200. PubMed ID: 32858404
[TBL] [Abstract][Full Text] [Related]
3. Use of a prospective surveillance model to prevent breast cancer treatment-related lymphedema: a single-center experience.
Yang EJ; Ahn S; Kim EK; Kang E; Park Y; Lim JY; Kim SW
Breast Cancer Res Treat; 2016 Nov; 160(2):269-276. PubMed ID: 27665585
[TBL] [Abstract][Full Text] [Related]
4. The Feasibility and Oncological Safety of Axillary Reverse Mapping in Patients with Breast Cancer: A Systematic Review and Meta-Analysis of Prospective Studies.
Han C; Yang B; Zuo WS; Zheng G; Yang L; Zheng MZ
PLoS One; 2016; 11(2):e0150285. PubMed ID: 26919589
[TBL] [Abstract][Full Text] [Related]
5. Risk factors of unilateral breast cancer-related lymphedema: an updated systematic review and meta-analysis of 84 cohort studies.
Shen A; Lu Q; Fu X; Wei X; Zhang L; Bian J; Qiang W; Pang D
Support Care Cancer; 2022 Dec; 31(1):18. PubMed ID: 36513801
[TBL] [Abstract][Full Text] [Related]
6. Factors Associated With Lymphedema in Women With Node-Positive Breast Cancer Treated With Neoadjuvant Chemotherapy and Axillary Dissection.
Armer JM; Ballman KV; McCall L; Ostby PL; Zagar E; Kuerer HM; Hunt KK; Boughey JC
JAMA Surg; 2019 Sep; 154(9):800-809. PubMed ID: 31314062
[TBL] [Abstract][Full Text] [Related]
7. The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-year follow-up prospective cohort study.
Zou L; Liu FH; Shen PP; Hu Y; Liu XQ; Xu YY; Pen QL; Wang B; Zhu YQ; Tian Y
Breast Cancer; 2018 May; 25(3):309-314. PubMed ID: 29397555
[TBL] [Abstract][Full Text] [Related]
8. Radiation therapy targets and the risk of breast cancer-related lymphedema: a systematic review and network meta-analysis.
Shaitelman SF; Chiang YJ; Griffin KD; DeSnyder SM; Smith BD; Schaverien MV; Woodward WA; Cormier JN
Breast Cancer Res Treat; 2017 Apr; 162(2):201-215. PubMed ID: 28012086
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: patient perceptions and precautionary behaviors.
McLaughlin SA; Wright MJ; Morris KT; Sampson MR; Brockway JP; Hurley KE; Riedel ER; Van Zee KJ
J Clin Oncol; 2008 Nov; 26(32):5220-6. PubMed ID: 18838708
[TBL] [Abstract][Full Text] [Related]
10. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis.
DiSipio T; Rye S; Newman B; Hayes S
Lancet Oncol; 2013 May; 14(6):500-15. PubMed ID: 23540561
[TBL] [Abstract][Full Text] [Related]
11. Prospective surveillance for breast cancer-related lymphedema (PROTECT).
Skjødt Rafn B; Jensen S; Bjerre ED; Wittenkamp MC; Benjaminsen K; Christensen LP; Flyger H; Christiansen P; Johansen C
Acta Oncol; 2023 Jul; 62(7):808-813. PubMed ID: 37042161
[No Abstract] [Full Text] [Related]
12. Prevalence and incidence of cancer related lymphedema in low and middle-income countries: a systematic review and meta-analysis.
Torgbenu E; Luckett T; Buhagiar MA; Chang S; Phillips JL
BMC Cancer; 2020 Jun; 20(1):604. PubMed ID: 32600278
[TBL] [Abstract][Full Text] [Related]
13. Loco-regional therapy and the risk of breast cancer-related lymphedema: a systematic review and meta-analysis.
Lin Y; Xu Y; Wang C; Song Y; Huang X; Zhang X; Cao X; Sun Q
Breast Cancer; 2021 Nov; 28(6):1261-1272. PubMed ID: 34106427
[TBL] [Abstract][Full Text] [Related]
14. The impact of monitoring techniques on progression to chronic breast cancer-related lymphedema: a meta-analysis comparing bioimpedance spectroscopy versus circumferential measurements.
Shah C; Zambelli-Weiner A; Delgado N; Sier A; Bauserman R; Nelms J
Breast Cancer Res Treat; 2021 Feb; 185(3):709-740. PubMed ID: 33245458
[TBL] [Abstract][Full Text] [Related]
15. The importance of detection of subclinical lymphedema for the prevention of breast cancer-related clinical lymphedema after axillary lymph node dissection; a prospective observational study.
Soran A; Ozmen T; McGuire KP; Diego EJ; McAuliffe PF; Bonaventura M; Ahrendt GM; DeGore L; Johnson R
Lymphat Res Biol; 2014 Dec; 12(4):289-94. PubMed ID: 25495384
[TBL] [Abstract][Full Text] [Related]
16. Clinical feasibility of Axillary Reverse Mapping and its influence on breast cancer related lymphedema: a systematic review.
Gebruers N; Tjalma WA
Eur J Obstet Gynecol Reprod Biol; 2016 May; 200():117-22. PubMed ID: 27019287
[TBL] [Abstract][Full Text] [Related]
17. Incidence and predictors of axillary web syndrome and its association with lymphedema in women following breast cancer treatment: a retrospective study.
Ryans K; Davies CC; Gaw G; Lambe C; Henninge M; VanHoose L
Support Care Cancer; 2020 Dec; 28(12):5881-5888. PubMed ID: 32270312
[TBL] [Abstract][Full Text] [Related]
18. Early intervention with compression garments prevents progression in mild breast cancer-related arm lymphedema: a randomized controlled trial.
Blom KY; Johansson KI; Nilsson-Wikmar LB; Brogårdh CB
Acta Oncol; 2022 Jul; 61(7):897-905. PubMed ID: 35657063
[TBL] [Abstract][Full Text] [Related]
19. Reducing rates of chronic breast cancer-related lymphedema with screening and early intervention: an update of recent data.
Whitworth P; Vicini F; Valente SA; Brownson K; DuPree B; Kohli M; Lawson L; Shah C
J Cancer Surviv; 2024 Apr; 18(2):344-351. PubMed ID: 35947288
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of axillary reverse mapping (ARM) in clinically axillary node negative breast cancer patients - Randomised controlled trial.
Abdelhamid MI; Bari AA; Farid MI; Nour H
Int J Surg; 2020 Mar; 75():174-178. PubMed ID: 32059974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
